000 01812 a2200505 4500
005 20250517132639.0
264 0 _c20171227
008 201712s 0 0 eng d
022 _a1872-9096
024 7 _a10.1016/j.antiviral.2016.12.022
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKuivanen, Suvi
245 0 0 _aObatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism.
_h[electronic resource]
260 _bAntiviral research
_cMar 2017
300 _a117-128 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAmides
_xpharmacology
650 0 4 _aAntiviral Agents
_xpharmacology
650 0 4 _aBrain
_xcytology
650 0 4 _aCaspases
_xmetabolism
650 0 4 _aDeoxycytidine
_xanalogs & derivatives
650 0 4 _aDrug Combinations
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aFetus
_xanatomy & histology
650 0 4 _aHumans
650 0 4 _aIndoles
650 0 4 _aMetabolic Networks and Pathways
_xdrug effects
650 0 4 _aPyrroles
_xpharmacology
650 0 4 _aRNA, Viral
_xmetabolism
650 0 4 _aRetinal Pigment Epithelium
_xcytology
650 0 4 _aSalicylates
_xpharmacology
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aVirus Replication
_xdrug effects
650 0 4 _aZika Virus
_xdrug effects
650 0 4 _aGemcitabine
700 1 _aBespalov, Maxim M
700 1 _aNandania, Jatin
700 1 _aIanevski, Aleksandr
700 1 _aVelagapudi, Vidya
700 1 _aDe Brabander, Jef K
700 1 _aKainov, Denis E
700 1 _aVapalahti, Olli
773 0 _tAntiviral research
_gvol. 139
_gp. 117-128
856 4 0 _uhttps://doi.org/10.1016/j.antiviral.2016.12.022
_zAvailable from publisher's website
999 _c26749537
_d26749537